)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Both CEAT and JK Tyre maintain that strong demand in the replacement tyre market is helping to cushion the impact of price hikes
The capital raised through this pledge is expected to support Mankind Pharma's strategic initiatives and growth plans
PV, 2W segments post their highest-ever domestic sales on demand spurred by Dussehra, Diwali
The firm aims to strengthen its presence in tier 2 and tier 3 cities, supported by an investment of approximately Rs 65 crore
Industry players said that regulatory bodies in India engage in private deliberations with firms, scrutinising and evaluating them before taking any supervisory action
Made in India compact SUV Kylaq will be exported
Sequentially, revenue from operations grew by 4.5 per cent, whereas PAT declined by 3.6 per cent
This decision delays Sun Pharma's planned US launch of the product, which could be deferred for several months if the company wins its appeal, or up to two years if it loses the case entirely
Festival demand boosts domestic sales by up to 26%; Bajaj figures decline
Plans to expand operations with Rs 650-cr outlay
Cipla eyes growth in the Indian and US markets with upcoming launches
The company launched 14 new products in India this quarter
With this launch, EMOBI aims to capture 20-25 per cent of the market share in India's B2B last-mile delivery sector over the next three years
The decline in PAT can be partly attributed to the deferred tax credit of Rs 21 crore, which the company received in the year-ago quarter
The company's stock fell 6.94 per cent to Rs 4,386.85 per share on Wednesday on the BSE
The company, which operates 280 labs across India and is on track to open 15-20 new labs this year as part of its expansion efforts, is also exploring acquisitions in southern India
HMIL's IPO had seen strong response from sovereign wealth funds and domestic mutual funds, but retail and wealthy investors sidestepped the issue amid a selloff in auto stocks and overall markets
Also plans to expand EV portfolio and production capacity
This contract follows a previous order from UPSRTC for 1,350 bus chassis, which are currently operational across Uttar Pradesh
They are updating dealership networks to offer customers a more luxurious lounge